Novel Vaccine for Leptospirosis

OCR Number: 
OCR 6320
  • Leptospira is a major veterinary pathogen and can cause a life-threatening disease in humans.
  • Current vaccines provide limited protective value.
  • Yale researchers have generated a live, attenuated strain that provides significant protective immunity.
  • Vaccination with this strain protects against a lethal challenge with various live Leptospira species.
  • OCR6320 is a safe and efficacious novel vaccine candidate for the treatment of Leptospira infections.
Licensing Contact: